ARCHIVES

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

UCSF Gets $20 Million For Stem Cell Research Building

February 4, 2011

Four Detroit Institutions Merge Cancer Clinical, Research Programs

July 15, 1994

In Brief: David Johnson New ACCC President, William Dugan Named President Elect; Straus Resigns From NYMC

March 12, 1982

In Brief: ASTRO Officers Named; AACR Fellowships Available; NRC Won’t Revoke NIH License

November 10, 1995

In Brief: Owens Gives Up Hopkins Hospital Presidency, Resume Full Time Role As Center Director

July 15, 1988

In Brief: Ford Decides Against Asking For Recision Of NCI Funds After Congress Overrides Verto

October 8, 1976